Alcohol Warning Labels for Drinking Habits
Trial Summary
What is the purpose of this trial?
This study aims to examine the effects of new front-of-package alcohol warnings on alcohol consumption. Participants will be randomly assigned to either new front-of-package health warnings or control labels. Participants will bring in their own alcohol to weekly study visits and take home the alcohol to consume as usual. Participants will receive study labels on their alcohol containers per their assigned trial arm.
Research Team
Marissa Hall, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Eligibility Criteria
This trial is for adults over 21 in the US who drink alcohol at least once a week, mostly from store-bought containers. They must be able to take surveys in English, not pregnant or breastfeeding, and willing to bring their own alcohol to study visits and respond to daily texts for 3 weeks. People with possible alcohol dependence or living with another participant are excluded.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Control label (Behavioral Intervention)
- Front-of-package health warning (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
Dr. Peggy P. McNaull
University of North Carolina, Chapel Hill
Chief Medical Officer
MD from Louisiana State University School of Medicine
Dr. Lynne Fiscus
University of North Carolina, Chapel Hill
Chief Executive Officer since 2020
MD from Georgetown University, MPH from UNC
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator
Dr. George F. Koob
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Chief Executive Officer since 2014
PhD in Neurobiology from the Scripps Research Institute
Dr. Patricia Powell
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Chief Medical Officer since 2015
MD from an accredited institution